EN
HI
Unjha Formulations Chart
Unjha Formulations Share Key Metrics
Volume
15.00
Market Cap
8.63 CR
LTQ@LTP
15@19.30
ATP
19.3
Var Margin
26.56 %
Circuit Range
15.44-23.16
Delivery %
100 %
Value
289.50
ASM/GSM
No
Market Lot
1
Summary
Unjha Formulations share price is ₹19.3 as of 29 May, 2026. The stock Unjha Formulations intraday movement has stayed between ₹19.30 and ₹19.30, while on a 52-week basis,Unjha Formulations price 52 week high is ₹30.40 & its 52 week low is ₹18.60.
In terms of trading activity, Unjha Formulations has recorded a volume of 15 shares, The Unjha Formulations has a market cap of ₹4480500 CR. The stock’s Average Traded Price (ATP) stands at ₹19.30, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15 @ ₹19.30.
Unjha Formulations operates within a circuit range of ₹15.44 – ₹23.16, with a Value of ₹289.50. The Delivery Percentage for the day is 100%. Additionally, Unjha Formulations currently falls under the No framework, and trades with a market lot size of 1.
Unjha Formulations Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
70.9
Sector P/B
3.02
Sec. Div. Yield
0.55
Unjha Formulations Resistance and Support
Pivot 19.3
Resistance
First Resistance
19.3
Second Resistance
19.3
Third Resistance
19.3
Support
First Support
19.3
Second Support
19.3
Third Support
19.3
Unjha Formulations Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-18 | Audited Results |
| 2026-02-04 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-03-17 | Others |
| 2025-02-04 | Quarterly Results |
Unjha Formulations News
Unjha Formulations Ltd - 531762 - Publish Audited Financial Results For The Quarter And Year Ended As On 31/03/2026
Unjha Formulations reported an audited FY26 net loss of Rs.34.02 lakhs, a 24.78% increase year-on-year. Despite a 14.07% rise in revenue to Rs.48.06 lakhs, the company's losses widened.
May 20 2026 15:35:34
Unjha Formulations Ltd - 531762 - Publish Audited Financial Results For The Quarter And Year Ended As On 31/03/2026
Unjha Formulations reported an audited FY26 net loss of Rs.34.02 lakhs, a 24.78% increase year-on-year. Despite a 14.07% rise in revenue to Rs.48.06 lakhs, the company's losses widened.
May 20 2026 15:33:51
Read More
Unjha Formulations Management
| Name | Position |
|---|---|
| Jashodaben S Patel | Chairperson |
| Krutiben M Patel | Managing Director & Compliance Officer |
Unjha Formulations Similar Stocks
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Parmax Pharma Ltd.
40.00
0.04 (0.10%)
Colinz Laboratories Ltd.
50.93
0.00 (0.00%)
Starsource Multitrade Ltd.
114.50
0.00 (0.00%)
Broach Lifecare Hospital Ltd.
16.00
0.00 (0.00%)
Ortin Global Ltd.
13.75
0.00 (0.00%)
Hindustan Bio Sciences Ltd.
8.60
0.00 (0.00%)
Dolphin Medical Services Ltd.
7.17
0.00 (0.00%)
Kabra Drugs Ltd.
25.40
0.18 (0.71%)
Unjha Formulations FAQs
The Buying Price of Unjha Formulations share is 19.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Unjha Formulations stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Unjha Formulations, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Unjha Formulations shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Unjha Formulations shares is 0. Useful to assess the stock's value relative to its book value.
To assess Unjha Formulations’s valuation compare Sector P/E, P/B which are 70.9 & 3.02 with sector averages, along with growth rates and financial metrics.
The Market Cap of Unjha Formulations is 8.63 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Unjha Formulations share price is 30.40 & 18.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Unjha Formulations belongs to the Healthcare sector.
